Efanesoctocog alfa clinical trials
4 indexed studies · 2 currently recruiting
- RecruitingPHASE1
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
This study is looking at a new medicine called efanesoctocog alfa for people with severe haemophilia A. It compares how long this new medicine stays in the body compared to two other similar medicines currently used. The goal is to see if the new medicine lasts longer.
For: Hemophilia ABulgaria · Germany · Italy - RecruitingPHASE4
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
This study looks at a new medicine called efanesoctocog alfa for people with haemophilia A. It aims to see if taking it once a week can reduce swelling in joints that are already affected.
For: Factor VIII DeficiencyUnited States · Canada · Japan - Active not recruitingPHASE3
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
This study is looking at how a new medicine, efanesoctocog alfa, affects physical activity and joint health in people aged 12 and over with severe haemophilia A. Participants will use a special activity tracker and diary.
For: Hemophilia A, SevereAustria · Croatia · Czechia - Active not recruitingPHASE4
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
This study looks at how well a medicine called efanesoctocog alfa works over a long time to keep joints healthy in people with haemophilia A. It aims to understand its real-world benefits in preventing bleeding into joints.
For: Hemophilia ACroatia · Czechia · France